Insurance-Based Disparities in Outcomes and ECMO Utilization for Hospitalized COVID-19 Patients.

Publication date: Mar 25, 2024

The objective of this study was to examine insurance-based disparities in mortality, non-home discharges, and ECMO utilization in patients hospitalized with COVID-19. Using a national database of U. S. academic medical centers and their affiliated hospitals, the risk-adjusted association between mortality, non-home discharge, and ECMO utilization and (1) the type of insurance coverage (private insurance, Medicare, dual enrollment in Medicare and Medicaid, and no insurance) and (2) the weekly hospital COVID-19 burden (0-5. 0%; 5. 1-10%, 10. 1-20%, 20. 1-30%, 30. 1%-) was evaluated. Modelling was expanded to include an interaction between payer status and the weekly hospital COVID-19 burden to examine whether the lack of private insurance was associated with increases in disparities as the COVID-19 burden increased. Among 760,846 patients hospitalized with COVID-19, 214,992 had private insurance, 318,624 had Medicare, 96,192 were dually enrolled in Medicare and Medicaid, 107,548 had Medicaid, and 23,560 had no insurance. Overall, 76,250 died, 211,702 had non-home discharges, 75,703 were mechanically ventilated, and 2,642 underwent ECMO. The adjusted odds of death were higher in patients with Medicare (aOR 1. 28; [95% CI: 1. 21, 1. 35]; P

Concepts Keywords
Death Based
Medicaid Burden
Weekly Covid
Disparities
Ecmo
Examine
Home
Hospitalized
Insurance
Medicaid
Medicare
Mortality
Non
Private
Utilization

Semantics

Type Source Name
disease MESH COVID-19
disease VO LACK
disease MESH death
disease MESH Long Covid

Original Article

(Visited 1 times, 1 visits today)